ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.508,67
1,09%
S&P 500
5.127,79
1,26%
US Dollar vs BRL
5,0724
0,00%
Bitcoin
64.313,67
2,28%
Brent Oil
82,765
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Oncternal Therapeutics Inc (ONCT)

  7. Oncternal Therapeutics Inc (ONCT) Notícias

ONCT

Oncternal Therapeutics (ONCT)

Oncternal Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ONCT
DataHoraFonteTítuloCódigoCompanhia
08/03/202418:42Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ONCTOncternal Therapeutics Inc
07/03/202418:20Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ONCTOncternal Therapeutics Inc
07/03/202418:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONCTOncternal Therapeutics Inc
27/02/202419:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
09/11/202318:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ONCTOncternal Therapeutics Inc
14/09/202317:01Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ONCTOncternal Therapeutics Inc
29/06/202307:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCTOncternal Therapeutics Inc
17/05/202317:06Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ONCTOncternal Therapeutics Inc
16/05/202317:13Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ONCTOncternal Therapeutics Inc
16/05/202317:10Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ONCTOncternal Therapeutics Inc
05/05/202317:02Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ONCTOncternal Therapeutics Inc
04/05/202317:43Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ONCTOncternal Therapeutics Inc
28/04/202317:02Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ONCTOncternal Therapeutics Inc
14/04/202319:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONCTOncternal Therapeutics Inc
17/03/202307:04Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ONCTOncternal Therapeutics Inc
05/01/202320:01Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ONCTOncternal Therapeutics Inc
05/11/202208:50TipRanksAnalysts Offer Insights on Healthcare Companies: Oncternal Therapeutics (ONCT) and Cutera (CUTR)NASDAQ:ONCTOncternal Therapeutics Inc
04/11/202207:45TipRanksOncternal Therapeutics (ONCT) Receives a Buy from H.C. WainwrightNASDAQ:ONCTOncternal Therapeutics Inc
02/09/202207:25TipRanksH.C. Wainwright Keeps Their Buy Rating on Oncternal Therapeutics (ONCT)NASDAQ:ONCTOncternal Therapeutics Inc
11/08/202208:20TipRanksAnalysts Have Conflicting Sentiments on These Healthcare Companies: Oncternal Therapeutics (ONCT) and 180 Life Sciences (ATNF)NASDAQ:ONCTOncternal Therapeutics Inc
10/08/202207:40TipRanksAnalysts Offer Insights on Healthcare Companies: Oncternal Therapeutics (ONCT), Arcturus Therapeutics (ARCT) and Foghorn Therapeutics (FHTX)NASDAQ:ONCTOncternal Therapeutics Inc
09/08/202221:45TipRanksBrookline Capital Markets Sticks to Their Buy Rating for Oncternal Therapeutics (ONCT)NASDAQ:ONCTOncternal Therapeutics Inc
08/07/202217:59Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ONCTOncternal Therapeutics Inc
11/06/202206:07TipRanksOncternal Therapeutics (ONCT) Gets a Buy Rating from BTIGNASDAQ:ONCTOncternal Therapeutics Inc
06/06/202207:35TipRanksAnalysts Offer Insights on Healthcare Companies: Aravive (ARAV), Oncternal Therapeutics (ONCT) and Curis (CRIS)NASDAQ:ONCTOncternal Therapeutics Inc
10/05/202209:42TipRanksAnalysts Have Conflicting Sentiments on These Healthcare Companies: Oncternal Therapeutics (ONCT), ICU Medical (ICUI) and Enanta Pharmaceuticals (ENTA)NASDAQ:ONCTOncternal Therapeutics Inc
09/05/202207:26TipRanksH.C. Wainwright Thinks Oncternal Therapeutics’ Stock is Going to RecoverNASDAQ:ONCTOncternal Therapeutics Inc
06/05/202214:15TipRanksBrookline Capital Markets Thinks Oncternal Therapeutics’ Stock is Going to RecoverNASDAQ:ONCTOncternal Therapeutics Inc
14/04/202206:15TipRanksAnalysts Are Bullish on Top Healthcare Stocks: CTI BioPharma (CTIC), Oncternal Therapeutics (ONCT)NASDAQ:ONCTOncternal Therapeutics Inc
18/03/202217:32Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ONCTOncternal Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:ONCT

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
HOOT4
HOTEIS OTHON PN
BOV
PRIO3
PETRORIO ON
BOV
TELB4
TELEBRAS PN
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados